The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease

被引:29
|
作者
Velasco, Nicolas [1 ]
Contreras, Alvaro [1 ]
Grassi, Bruno [1 ]
机构
[1] Pontificia Univ Catolica Chile, Sch Med, Dept Nutr Diabet & Metab, Santiago, Chile
关键词
diet therapy; fatty liver; liver diseases; Mediterranean diet; nonalcoholic fatty liver disease; METABOLIC SYNDROME; RISK; ADHERENCE; PATTERN; CANCER; INDIVIDUALS; IMPROVES; OBESITY;
D O I
10.1097/MCO.0000000000000071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The purpose of this review is to present the pathophysiological mechanisms and most recent clinical evidence regarding the role of the Mediterranean diet in preventing and treating nonalcoholic fatty liver disease (NAFLD). Recent findings Several components of the Mediterranean diet have proven benefits in controlling the pathophysiological mechanisms involved in NAFLD. However, the few clinical studies that have assessed the diet have involved low numbers of patients and lacked methodological rigor. The results of these studies suggest that the Mediterranean diet attenuates the progression of NAFLD once it is established, but does not contribute to preventing the disease in patients at risk. Summary Although there is a lack of clinical evidence derived from studies with high-quality methodology, the pathophysiological mechanisms of NAFLD shared with other associated pathologies suggest that there is a role for the Mediterranean diet in managing NAFLD. Studies with better methodology are needed to confirm the impact of the diet.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 50 条
  • [41] Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
    Fedchuk, L.
    Nascimbeni, F.
    Pais, R.
    Charlotte, F.
    Housset, C.
    Ratziu, V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (10) : 1209 - 1222
  • [42] Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Giovanni Tarantino
    World Journal of Gastroenterology, 2007, (35) : 4669 - 4672
  • [43] Should nonalcoholic fatty liver disease be regarded as a hepatic illness only?
    Tarantino, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (35) : 4669 - 4672
  • [44] Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial
    George, Elena S.
    Reddy, Anjana
    Nicoll, Amanda J.
    Ryan, Marno C.
    Itsiopoulos, Catherine
    Abbott, Gavin
    Johnson, Nathan A.
    Sood, Siddharth
    Roberts, Stuart K.
    Tierney, Audrey C.
    LIVER INTERNATIONAL, 2022, 42 (06) : 1308 - 1322
  • [45] Mediterranean diet and non-alcoholic fatty liver disease. The need of extended and comprehensive interventions
    Trovato, Francesca M.
    Catalano, Daniela
    Martines, G. Fabio
    Pace, Patrizia
    Trovato, Guglielmo M.
    CLINICAL NUTRITION, 2015, 34 (01) : 86 - 88
  • [46] Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
    Nadinskaia, Maria
    Maevskaya, Marina
    Ivashkin, Vladimir
    Kodzoeva, Khava
    Pirogova, Irina
    Chesnokov, Evgeny
    Nersesov, Alexander
    Kaibullayeva, Jamilya
    Konysbekova, Akzhan
    Raissova, Aigul
    Khamrabaeva, Feruza
    Zueva, Elena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (10) : 959 - 975
  • [47] Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
    Marinho, Polyana C.
    Vieira, Aline B.
    Pereira, Priscila G.
    Rabelo, Kissila
    Ciambarella, Bianca T.
    Nascimento, Ana L. R.
    Cortez, Erika
    Moura, Anibal S.
    Guimaraes, Fernanda V.
    Martins, Marco A.
    Barquero, Gonzalo
    Ferreira, Rodrigo N.
    de Carvalho, Jorge J.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018
  • [48] Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease
    Pirmoazen, Amir M.
    Khurana, Aman
    Loening, Andreas M.
    Liang, Tie
    Shamdasani, Vijay
    Xie, Hua
    El Kaffas, Ahmed
    Kamaya, Aya
    INVESTIGATIVE RADIOLOGY, 2022, 57 (01) : 23 - 32
  • [49] The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial
    Araceli Marin-Alejandre, Bertha
    Abete, Itziar
    Cantero, Irene
    Ignacio Monreal, J.
    Elorz, Mariana
    Ignacio Herrero, Jose
    Benito-Boillos, Alberto
    Quiroga, Jorge
    Martinez-Echeverria, Ana
    Isidro Uriz-Otano, Juan
    Pilar Huarte-Muniesa, Maria
    Tur, Josep A.
    Alfredo Martinez, J.
    Angeles Zulet, M.
    NUTRIENTS, 2019, 11 (10)
  • [50] Nonalcoholic Fatty Liver Disease
    Isaacs, Scott
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 149 - 164